Sign In
Buy NUVA
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive Announces New Executive Leadership Roles
04:10pm, Wednesday, 01'st Sep 2021
SAN DIEGO , Sept. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integ
NuVasive to Present at Upcoming Investor Conference
07:00am, Monday, 30'th Aug 2021
SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive: A Compelling And Comprehensive Spine Surgery Play
11:50am, Monday, 16'th Aug 2021
NuVasive's XLIF procedure and Pulse platform will drive its long-term revenue growth. In addition, the company's surgical access instruments will drive revenue growth as well.
This Revolutionary Medical Device Company Goes to 11
06:12am, Friday, 13'th Aug 2021
To stand tall against a competitive market, NuVasive depends on a strong spinal platform.
Amy Belt Raimundo to Join NuVasive Board of Directors
04:10pm, Monday, 09'th Aug 2021
SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integra
NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch
07:00am, Friday, 30'th Jul 2021
SAN DIEGO, July 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Q2 Earnings Beat Estimates, Gross Margin Up
11:25am, Thursday, 29'th Jul 2021
NuVasive (NUVA) reports strong segmental and geographical performance driving the top line in second-quarter 2021.
NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2021 Results - Earnings Call Transcript
09:26pm, Wednesday, 28'th Jul 2021
NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2021 Results - Earnings Call Transcript
NuVasive (NUVA) Beats Q2 Earnings and Revenue Estimates
06:59pm, Wednesday, 28'th Jul 2021
NuVasive (NUVA) delivered earnings and revenue surprises of 39.54% and 3.03%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
NuVasive Announces Second Quarter 2021 Financial Results
04:10pm, Wednesday, 28'th Jul 2021
SAN DIEGO, July 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
NuVasive (NUVA) Launches Modulus ALIF for Anterior Spine Surgery
08:27am, Friday, 23'rd Jul 2021
The Modulus ALIF 3D-printed porous titanium implant is the latest addition to NuVasive's (NUVA) AMS portfolio for anterior lumbar interbody fusion procedures.
NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
07:00am, Thursday, 22'nd Jul 2021
SAN DIEGO, July 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integra
NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results
04:10pm, Wednesday, 14'th Jul 2021
SAN DIEGO, July 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
FDA Flags Certain Biocompatibility Concerns For NuVasive's Orthopedics' Precice Devices
09:51am, Friday, 09'th Jul 2021
The FDA informed healthcare providers of potential biocompatibility concerns with NuVasive Inc's (NASDAQ:NUVA) specialized orthopedics' Precice devices. Precice devices are implants for 18 years of
NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations
07:00am, Wednesday, 30'th Jun 2021
SAN DIEGO, June 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integr
